Alliance for mRNA Medicines
Become a Member
Home / Event / SAVE THE DATE – AMM ASCENT
IN-PERSON

SAVE THE DATE – AMM ASCENT

October 29-30, 2026  |  Coronado Island Marriott Resort and Spa 2000 2nd St, Coronado, CA 92118

ABOUT THIS EVENT

The Alliance for mRNA Medicines (AMM) brings together senior executives and top decision-makers in the mRNA industry to advance pioneering research into vaccines and therapies for patients. The annual meeting, AMM ASCENT (Advancements in mRNA Science, Commercialization, Education, and Novel Technologies), features one-on-one partnering opportunities for companies and investors, dedicated networking, keynotes and fireside chats featuring KOLs and industry visionaries, as well as engaging plenary and panel discussions among biotech, pharma, and academic leaders.

WHY ATTEND

1-on-1 Partnering

Through the power of the partneringONE partnering platform, attendees can search, connect, and schedule 1:1 meetings with potential partners to identify opportunities, build relationships, and move deals forward.

Networking Events

Ample dedicated networking opportunies to connect with other industry leaders and potential partners.

Plenary Sessions & Panel Discussions

Learn from senior executives and top decision-makers in the mRNA industry to advance pioneering research into vaccines and therapies for patients with engaging speakers, fireside chats, and panel discussions.

SPONSORS

AMM is grateful to the partners whose support is making AMM ASCENT possible. Interested in becoming a sponsor? Contact contact@mrnamedicines.org to learn more and check out our sponsor prospectus here.

About AMM

The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering mRNA industry leaders, innovators, scientists, and other key stakeholders.